VORICONAZOLE-MEDIS voriconazole 50mg tablet blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

voriconazole, Quantity: 50 mg

Inapatikana kutoka:

Medis Pharma Pty Ltd

INN (Jina la Kimataifa):

Voriconazole

Dawa fomu:

Tablet, film coated

Tungo:

Excipient Ingredients: lactose monohydrate; magnesium stearate; povidone; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; hypromellose; triacetin; macrogol 3350

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

56, 10, 2, 30, 28, 50, 14, 20, 100

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

VORICONAZOLE-MEDIS is indicated for treatment of the following fungal infections:,Invasive aspergillosis.,Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,Serious fungal infections caused by Scedosporium spp and Fusarium spp.,Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation. This brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets.

Bidhaa muhtasari:

Visual Identification: white, round biconvex tablets, debossed 'VC50' on one side and plain on the reverse; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2015-02-02